CONTEXT: Neuroradiology fellow Dr. Roula Hourani at Johns Hopkins University researched the ability of proton MR spectroscopy (MRS) to differentiate between benign brain neoplasia and tumors in children. Potentially, such a non-invasive diagnostic approach would most benefit children with non-neoplastic lesions and less accessible tumors that could be treated by radio- or chemotherapy.
CONTEXT: Neuroradiology fellow Dr. Roula Hourani at Johns Hopkins University researched the ability of proton MR spectroscopy (MRS) to differentiate between benign brain neoplasia and tumors in children. Potentially, such a non-invasive diagnostic approach would most benefit children with non-neoplastic lesions and less accessible tumors that could be treated by radio- or chemotherapy.
RESULTS: MRI and high-resolution multislice proton MRS (three to four 15-mm slices separated by 2.5 mm) were performed on 36 children with primary brain lesions on a 1.5T scanner using a standard birdcage head coil. Resolution of 0.8-mL voxel size was the same in all experiments. MRS provided data on choline (Cho) and creatine (Cr), revealing that tumors and non-neoplastic lesions could be distinguished by differences in the Cho/Cr ratio, with tumors having a higher Cho/Cr ratio.
IMAGE: Comparison of proton MR spectra of a benign thalamic lesion (A: acute disseminated encephalomyelitis, nine-year-old female) and a tumor (B: pilocytic astrocytoma, 12-year-old male). A higher Cho/Cr ratio was detected in the tumor (Cho/Cr = 2.03) than in the benign lesion (Cho/Cr = 0.80).
IMPLICATIONS: This is the first study to apply multislice MRS sequences to differentiate nonneoplastic lesions from tumors in children. The study provides preliminary data that proton MRS can help evaluate pediatric brain lesions. The approach holds the most promise in identifying inaccessible and benign lesions (avoiding the need for biopsy). The next step in this work is a prospective study combining spectroscopy with other MRI techniques, such as perfusion, according to researcher Alena Horska, Ph.D, an assistant professor of radiology at Johns Hopkins.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Multicenter CT Study Shows Benefits of Emerging Diagnostic Model for Clear Cell Renal Cell Carcinoma
May 15th 2024Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.